An 18-yr-old woman with clinical and laboratory features of hyperthyroidism had persistently elevated serum levels of immunoreative thyrotropin (TSH). During 11 yr of follow-up there had been no evidence of a pituitary tumor. After thyrotropin-releasing hormone (TRH), there was a marked increase in TSH and secondarily in triiodothyronine (T3), the latter observation confirming the biologic activity of the TSH. Exogenous T3 raised serum T3 and several measurements of peripheral thyroid hormone effect, while decreasing serum TSH, thyroxine (T4), and thyroidal radioiodine uptake. After T3, the TRH-stimulated TSH response was decreased but was still inappropriate for the elevated serum T3 levels. Dexamethasone reduced serum TSH but did not inhibit TRH stimulation of TSH. Propylthiouracil reduced serum T4 and T3 and raised TSH. This patient represents a new syndrome of TSH-induced hyperthyroidism, differing from previous reports in the absence of an obvious pituitary tumor and in the responsiveness of the TSH to TRH stimulation and thyroid hormone suppression. This syndrome appears to be caused by a selective, partial resistance of the pituitary to the action of thyroid hormone. This case is also compared with previous reports in the literature of patients with elevated serum levels of immunoreactive TSH in the presence of elevated total and free thyroid hormones. A classification of these cases, termed "inappropriate secretion of TSH," is proposed.
A B S T R A C T An 18-yr-old woman with clinical and laboratory features of hyperthyroidism had persistently elevated serum levels of immunoreactive thyrotropin (TSH). During 11 yr of follow-up there had been no evidence of a pituitary tumor. After thyrotropin-releasing hormone (TRH), there was a marked increase in TSH and secondarily in triiodothyronine (T3), the latter observation confirming the biologic activity of the TSH. Exogenous T3 raised serum Ts and several measurements of peripheral thyroid hormone effect, while decreasing serum TSH, thyroxine (T4), and thyroidal radioiodine uptake. After T3, the TRH-stimulated TSH response was decreased but was still inappropriate for the elevated serum Ta levels. Dexamethasone reduced serum TSH but did not inhibit TRH stimulation of TSH. Propylthiouracil reduced serum T4 and Ts and raised TSH. This patient represents a new syndrome of TSH-induced hyperthyroidism, differing from previous reports in the absence of an obvious pituitary tumor and in the responsiveness of the TSH to TRH stimulation and thyroid hormone suppression. This syndrome appears to be caused by a selective, partial resistance of the pituitary to the action of thyroid hormone. This case is also compared with previous reports in the literature of patients with elevated serum levels of immunoreactive TSH in the presence of elevated total and free thyroid hormones. A classification of these cases, termed "inappropriate secretion of TSH," is proposed.
INTRODUCTION
Serum thyrotropin (TSH)1 is usually suppressed in clinical disorders associated with the hypersecretion of thyroid hormones, thyroxine (T4), and triiodothyronine (T3) (1) (2) (3) (4) . However, recently the combination of elevated serum TSH and thyroid hormones has been described in a few patients. Even this small group appears heterogeneous, since clinical features of the patients and proposed pathogenesis of the TSH hypersecretion differ. Hamilton, Adams, and Maloof (5), Faglia et al. (6) , O'Donnell, Hadden, Weaver, and Montgomery (7), and Mornex et al. (8) studied patients with pituitary tumors, hypersecretion of TSH and hyperthyroidism, while Hamilton and Maloof (9) described a similar patient who also had acromegaly. ' Refetoff, DeGroot, Benard, and DeWind (10, 11), Bode, Danon, Weintraub, Maloof, and Crawford (12) , and Lamberg (13) have described clinically euthyroid patients with elevated serum thyroid hormones and TSH who appear to have varying degrees of tissue resistance to the action of thyroid hormones and elevated serum TSH. More recently, Emerson and Utiger (14) reported a patient with hyperthyroidism and elevated serum TSH but without evidence of a pituitary tumor. In their case 1Abbreziations used in this paper: PBI, protein-bound iodine; Ts, triiodothyronine; T4, thyroxine; TRH, thyrotropin-releasing hormone; TSH, thyrotropin.
'In this paper the designation "TSH" is restricted to hormone measured by specific radioimmunoassay. Before the availability of radioimmunoassay, TSH was measured by relatively nonspecific bioassays, which did not always differentiate among various thyroid-stimulating substances. Several older reports that showed an association of pituitary tumor, hyperthyroidism, and increased serum thyroidstimulating activity are not considered in this paper. 
METHODS
Serum TSH was measured by a double-antibody radioimmunoassay with a sensitivity of 0.5 /AU/ml of serum; the range of normal values was <0.5-3.5 ,U/ml with a mean of 1.7 iuU/ml (4) . Serum T4 was measured by competitive protein-binding analysis (15) , and serum Ts (16) and prolactin (17) were measured by radioimmunoassay. A variety of other hormone measurements and endocrine tests were performed by previously published methods (see references, Table II ). TRH, 500 gg, was injected rapidly i.v., and blood was collected at -10, 0, 15, 20, 30, 45, 60, 120, and 180 min for measurement of TSH and at 0, 60, and 180 min for Ts. The peak TSH response in normals was 5-30 pU/ml; in hyperthyroid patients with Graves' disease, toxic multinodular goiter, or toxic adenoma, there was no TSH response detected, as previously reported (2) (3) (4) . RESULTS Base-line studies. Basal thyroid function studies are outlined in Table I . All measurements of thyroid hormones were elevated (T4 was 12.7,ug/dl, free T4 was 2.7 ng/dl, Ts was 220 ng/dl), and the binding proteins were normal (thyroxine-binding globulin capacity was 19 ug of T4/dl). The TSH was not only absolutely elevated (9.3 gU/ml), but was particularly inappropriate relative to the elevated thyroid hormone levels normally associated with suppressed TSH (< 0.5 uU/ml) (1-4). Thyroidal hyperactivity was shown by elevated 'I uptake (4-h was 26%, 24-h was 43%) and [181I] PBI (0.14% of dose/liter at 48 h). Peripheral hyperthyroidism, that is excessive effect of thyroid hormone on peripheral tissues, was documented by elevated BMR of + 20% (18), shortened pulse-wave arrival time (QKd interval) of 135 ms (19) , and elevated red cell sodium content of 9.4 mmol/liter of cells (20) .
Stimulation by TRH on day 2 ( Fig. 1) The integrity of secretion of the other anterior pituitary hormones and their effectiveness at their respective target organs were studied both in the basal state and after provocative stimuli (22-24, clined from 9.3 to 2.0 AU/ml (Fig. 2) . The serum T8 was probably much higher than this minimal level through most of the day (25) . The thyroidal response to the lowered circulating TSH concentration was manifested by a decline in the uptake of radioiodine at 4 h from 26 (26) . (28) . Sustained deficiencies of thyroid hormones, produced by radiothyroidectomy, caused hypertrophy and hyperplasia of the pituitary thyrotrophs, which led eventually to autonomous thyrotropic tumors. These tumors secreted large amounts of TSH in addition to several other trophic hormones.
Ectopic production of pituitary TSH has not yet been demonstrated. However, hyperthyroidism has been associated with several tumors of trophoblastic origin (29) (30) (31) , which produced substances with bioassayable thyroid-stimulating activity but no immunologic relation to pituitary TSH.
Elevated serum thyroid hormone and TSH levels have been found in several patients who demonstrated resistance to the action of thyroid hormone. Refetoff et al. (10, 11) described a familial syndrome of deafmutism, stippled epiphyses, goiter, elevated thyroid hormone levels, detectable circulating TSH, and a euthyroid clinical state in three of six siblings. In these studies certain tests of the peripheral action of thyroid hormones yielded results compatible with hypothyroidism, while others suggested euthyroidism. More re- In our case the cause of the TSH hypersecretion appears to be a selective resistance of the pituitary to the action of thyroid hormone. Interestingly, this resistance may not be confined to thyrotrophs but may also be shared by somatotrophs and lactotrophs. Although the patient's serum growth hormone and prolactin were normal in the basal state, both hormones showed increased responses to provocative stimuli. These increased responses were particularly striking in view of the elevated serum thyroid hormones, shown in certain instances to blunt the growth hormone response to hypoglycemia (35) as well as the prolactin response to TRH (22) in humans. Moreover, neoplastic rat pituitary cell lines that secrete both prolactin and growth hormone in vitro have been shown to have highaffinity nuclear receptors for thyroid hormone (36) .
The pituitary resistance to thyroid hormone in this patient was only partial, since the TSH responded to both stimulatory and suppressive factors as in patients with primary hypothyroidism. Specifically, there was an exaggerated TSH response to exogenous TRH stimulation, blunting of the TSH response to TRH by thyroid hormone, and blunting of basal TSH but not of TRH-stimulated TSH secretion by dexamethasone. However, unlike patients with primary hypothyroidism (or normals) our patient achieved a normal basal TSH and response to TRH only with markedly elevated serum Ts levels. In fact, we have not yet determined what dose of thyroid hormone would be required to suppress both basal and TRH-responsive TSH totally. As described above, these data are not compatible solely with hypersecretion of endogenous TRH. This syndrome is, therefore, functionally analogous to Cushing's disease, in which there is a qualitatively normal but quantitatively abnormal response of ACTH to glucocorticoid suppression. However, the histopathology of the pituitary as well as the biochemical basis for resistance to thyroid hormone in this disorder remain to be elucidated.
